Immunotherapy Serine-Threonine Kinase Inhibitors EGFR Tyrosine Kinase Inhibitors Other PI3 Kinase Inhibitors CD Protein Inhibitors Immune Checkpoint Inhibitors Threonine-Tyrosine Kinase Inhibitors Wnt Signaling Inhibitors PARP Inhibitors | Colorectal Cancer | Pancreatic Ductal Adenocarcinoma | Bladder Cancer |
---|---|---|---|
avelumab + binimetinib | |||
cetuximab + alpelisib + encorafenib | |||
encorafenib | |||
JPI-547 | |||
Immunotherapy | |||
PORCN inhibitor |